Sibil M. Pathickal, RPAC

Sibil Pathickal practices at NYU Langone - Tisch Hospital in New York, New York.

Sibil Pathickal's NPI, 1669846770, was assigned on December 1, 2015. Sibil Pathickal holds New York license 019139.

Sibil Pathickal's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Sibil Pathickal's primary practice is NYU Langone - Tisch Hospital in New York, New York. Sibil Pathickal is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Sibil Pathickal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sibil Pathickal practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Sibil Pathickal's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sibil Pathickal is licensed in New York.

Dmand AI lists acute sinusitis, anxiety, asthma, chronic obstructive pulmonary disease (COPD), gastroenteritis, lower back pain, muscle pain, fibromyalgia, and limb pain and pneumonia among the conditions Sibil Pathickal treats.

CMS data shows 192 Medicare services from Sibil Pathickal across 2 procedure codes in 2024, all of them office visits, for 146 Medicare patients. Medicare paid $12,287 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Sibil Pathickal in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sibil Pathickal's median patient age at 50, with 41% women.

In 2024, Sibil Pathickal wrote 1,023 Medicare Part D claims for 322 patients. 60% of them were for generic drugs. CMS names the drug for 687 of them, across 27 drugs with 11 or more claims each, at $160,539 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Sibil Pathickal for performance year 2024, reported as part of a group. Sibil Pathickal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sibil Pathickal as offering telehealth.

CMS Open Payments shows 4 general payments to Sibil Pathickal from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $71.